NOVO.B.DK

316.2

-1.72%↓

GMAB.DK

1,995

-1.19%↓

HLUNB.DK

43.22

-0.41%↓

ZEAL.DK

491.1

-0.34%↓

NOVO.B.DK

316.2

-1.72%↓

GMAB.DK

1,995

-1.19%↓

HLUNB.DK

43.22

-0.41%↓

ZEAL.DK

491.1

-0.34%↓

NOVO.B.DK

316.2

-1.72%↓

GMAB.DK

1,995

-1.19%↓

HLUNB.DK

43.22

-0.41%↓

ZEAL.DK

491.1

-0.34%↓

NOVO.B.DK

316.2

-1.72%↓

GMAB.DK

1,995

-1.19%↓

HLUNB.DK

43.22

-0.41%↓

ZEAL.DK

491.1

-0.34%↓

NOVO.B.DK

316.2

-1.72%↓

GMAB.DK

1,995

-1.19%↓

HLUNB.DK

43.22

-0.41%↓

ZEAL.DK

491.1

-0.34%↓

Search

Coloplast A-S (Class B)

Deschisă

567 0.64

Rezumat

Modificarea prețului

24h

Curent

Minim

559.2

Maxim

568

Indicatori cheie

By Trading Economics

Venit

-107M

805M

Vânzări

28M

7B

P/E

Medie Sector

34.765

77.671

EPS

3.88

Randament dividend

3.96

Marjă de profit

11.569

Angajați

16,744

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+11.86% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

3.96%

2.35%

Statistici piață

By TradingEconomics

Capitalizare de piață

-10B

127B

Deschiderea anterioară

566.36

Închiderea anterioară

567

Coloplast A-S (Class B) Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

14 dec. 2025, 22:53 UTC

Achiziții, Fuziuni, Preluări

Fortescue to Take Full Control of US$101 Million Copper Miner Alta

13 dec. 2025, 00:04 UTC

Achiziții, Fuziuni, Preluări

Intel in Talks to Acquire SambaNova in Deal Valued at $1.6 Billion, Bloomberg Reports, Citing Sources

14 dec. 2025, 23:46 UTC

Market Talk

Gold Edges Higher Amid Some Tailwinds -- Market Talk

14 dec. 2025, 23:36 UTC

Market Talk

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

14 dec. 2025, 22:38 UTC

Achiziții, Fuziuni, Preluări

Fortescue to Take Full Control of US$101M Copper Miner Alta

14 dec. 2025, 22:02 UTC

Achiziții, Fuziuni, Preluări

Fortescue: Transaction Is Consistent With Critical Minerals Strategy

14 dec. 2025, 22:01 UTC

Achiziții, Fuziuni, Preluări

Fortescue: Alta Owns the Canariaco Project in Northern Peru

14 dec. 2025, 22:01 UTC

Achiziții, Fuziuni, Preluări

Fortescue: Alta Directors Unanimously Recommend Proposal, Will Vote in Favor

14 dec. 2025, 22:00 UTC

Achiziții, Fuziuni, Preluări

Fortescue: Agreement Implies Total Equity Value of C$139 Million

14 dec. 2025, 22:00 UTC

Achiziții, Fuziuni, Preluări

Fortescue to Pay C$1.40/Share for Securities It Does Not Already Own

14 dec. 2025, 21:59 UTC

Achiziții, Fuziuni, Preluări

Fortescue to Acquire Remaining 64% of Alta Copper

14 dec. 2025, 17:00 UTC

Câștiguri

Tonka Trucks Gambled on Keeping Production in China and Survived -- Barely -- WSJ

14 dec. 2025, 08:30 UTC

Achiziții, Fuziuni, Preluări

Kymera Had a Big Week. This Secretive Hedge Fund Bought $172 Million of Its Stock. -- Barrons.com

13 dec. 2025, 16:48 UTC

Achiziții, Fuziuni, Preluări

How the War to Win Warner Bros. Discovery Will Be Won -- Barrons.com

13 dec. 2025, 08:00 UTC

Achiziții, Fuziuni, Preluări

How the War to Win Warner Bros. Discovery Will Be Won -- Barrons.com

13 dec. 2025, 07:00 UTC

Achiziții, Fuziuni, Preluări

A Chubb/AIG Deal Could Be Good for Shareholders and a Coup for Greenberg Family -- Barrons.com

13 dec. 2025, 00:24 UTC

Achiziții, Fuziuni, Preluări

Want a Piece Of SpaceX? -- Barrons.com

12 dec. 2025, 23:49 UTC

Achiziții, Fuziuni, Preluări

Intel in Talks to Acquire SambaNova in Deal Valued at $1.6B, Bloomberg Reports, Citing Sources

12 dec. 2025, 22:52 UTC

Market Talk

Nike Expected to Show Further Momentum in 2Q Results -- Market Talk

12 dec. 2025, 22:32 UTC

Câștiguri

These Stocks Moved the Most Today: Broadcom, Oracle, Fermi, Tilray, Lululemon, Costco, Netskope, and More -- Barrons.com

12 dec. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

12 dec. 2025, 20:45 UTC

Câștiguri

The Best Dividend ETF for Right Now -- and 2026 -- Barrons.com

12 dec. 2025, 20:41 UTC

Market Talk

Oil Ends Week Lower As Market Frets About Oversupply -- Market Talk

12 dec. 2025, 20:20 UTC

Market Talk

U.S. Natural Gas Futures Post Hefty Weekly Loss -- Market Talk

12 dec. 2025, 19:23 UTC

Câștiguri

Charles Schwab Is Opening New Accounts and Hauling in New Assets Amid Buoyant Stock Market -- Barrons.com

12 dec. 2025, 18:35 UTC

Achiziții, Fuziuni, Preluări

PNC Financial Expects to Close FirstBank Deal On or About Jan. 5, Subject to Satisfaction of Customary Closing Conditions

12 dec. 2025, 18:33 UTC

Achiziții, Fuziuni, Preluări

PNC Receives Regulatory Approvals For Acquisition Of FirstBank >PNC

12 dec. 2025, 18:31 UTC

Market Talk

U.S. Oil Rig Count Edges Up by 1 to 414 -- Market Talk

12 dec. 2025, 17:49 UTC

Câștiguri

Tariffs Mean Costco Has Fewer Product Types This Holiday. But It Has Plenty of Pies. -- WSJ

12 dec. 2025, 17:34 UTC

Achiziții, Fuziuni, Preluări

Orange: Closing Subject to Customary Regulatory Approvals, Other Closing Conditions

Comparație

Modificare preț

Coloplast A-S (Class B) Așteptări

Obiectiv de preț

By TipRanks

11.86% sus

Prognoză pe 12 luni

Medie 901.38 DKK  11.86%

Maxim 1,056 DKK

Minim 720 DKK

În baza a 8 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruColoplast A-S (Class B) - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

8 ratings

2

Cumpărare

4

Păstrare

2

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat